SWIFTWATER, PA-As Lyon, France-based Sanofi Pasteur anticipates a late 2008, early 2009 opening of a new 140,000-sf influenza vaccine facility here it also has been awarded a $77.4-million contract by the US Department of Health and Human Services to retrofit its existing flu vaccine facility at this site. The total cost of both projects is estimated at $252.4 million.

The Commonwealth Financing Authority provided Pocono Township with a $5-million grant from its PennWorks program for sewer improvements along the Route 611 corridor to serve the company’s site on Discovery Drive. A Sanofi Pasteur spokeswoman tells GlobeSt.com the cost of constructing the new facility is $150 million. “The facility is now beginning the process of obtaining FDA licensing,” she says.

The design phase of the retrofit has begun, and Sanofi Pasteur will add approximately $25 million to the HHS grant. Once the new building is licensed by the FDA and operational, the existing facility will be phased out and decommissioned for the retrofit. The design, retrofit and maintenance of the facilities will place them in a state of readiness so the company can switch to pandemic influenza vaccine manufacture at HHS’s request.

The existing plant has produced approximately 50 million doses of vaccine for the US market during the past several influenza seasons. When both facilities here are validated, capacity will be approximately triple current output. Sanofi Pasteur is the vaccines division of the Sanofi-Aventis Group.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.